Recent Trends in Prescription Drug Costs
Recent Trends in Prescription Drug Costs_JAMA 040516 Download View JAMA infographic…
View the Latest: Prices
Filter
-
-
Visualizing Health Policy: Recent Trends in Prescription Drug Costs
OtherThis Visualizing Health Policy infographic with JAMA spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices.
-
Visualizing Health Policy: Recent Trends in Prescription Drug Costs
News ReleaseThis Visualizing Health Policy infographic spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices. Prescription drug spending rose sharply in 2014, driven by growth in expenditures on specialty drugs, including medications to treat cancer and hepatitis C.
-
Assessing Online Availability of At-Home COVID-19 Tests Ahead of Private Insurance Reimbursement
Issue BriefThis data note explores findings from on an 8-day online search for at home COVID-19 tests at major retailers. The findings are described against the backdrop of the Biden Administration policy requiring plans to cover the cost of these tests. We find that these tests remain hard to find and that this limited availability could negatively affect the success of the reimbursement strategy.
-
The Only Health Care Prices That Matter to Consumers
From Drew AltmanIn this column, Drew Altman zeroes in on a key test for when the implementing rules are written for the new executive order on hospital price transparency: consumers will need to know what amount they must pay out of pocket to really help them shop on price.
-
Explainer Video Breaks Down Prescription Drug Rebates and Why They Matter in the Debate About Prescription Drug Costs
News ReleaseA new KFF animation explains how rebates for prescription drugs work, including how they are determined, who benefits from them, how they affect spending by insurers and consumers and the role of pharmacy benefit managers in the process.
-
Annual Out-of-Pocket Costs for Insulin Nearly Doubled Over a Decade for Medicare Part D Enrollees
FeatureOut-of-pocket insulin costs for Medicare Part D enrollees with incomes too high to qualify for low-income subsidies increased 81% from 2007 to 2016. Learn more in the latest Chart of the Week.
-
The Sleeper Health Cost Policy
From Drew AltmanIn this Axios column, Drew Altman unpacks President Biden’s recent executive order on promoting competition, exploring its significance for new efforts to control health costs by addressing consolidation in the health care industry.
-
Dec. 8 Event: Unpacking the Prescription Drug Provisions of the Build Back Better Act
Event Date:EventAs the Build Back Better Act shifts from the House to the Senate, there’s considerable interest in provisions that would lower the cost of prescription drugs.
-
Large Majorities Across Parties Favor Allowing the Federal Government to Negotiate Drug Prices, Even After Hearing Common Arguments About It
News ReleaseMost of the Public Lacks Confidence that President Biden, Congressional Democrats or Republicans Will Do the Right Thing on Drug Prices Allowing the federal government to negotiate with drug companies to lower drug prices for Medicare beneficiaries and people enrolled in private plans – a key cost-saving proposal in the Democrats’ massive reconciliation bill –…